rs36038536
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM5PP3_ModeratePP5
The NM_017739.4(POMGNT1):c.1099C>T(p.Arg367Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,552 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R367H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_017739.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000240 AC: 6AN: 249980 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461400Hom.: 0 Cov.: 33 AF XY: 0.0000454 AC XY: 33AN XY: 726954 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 367 of the POMGNT1 protein (p.Arg367Cys). This variant is present in population databases (rs36038536, gnomAD 0.01%). This missense change has been observed in individual(s) with POMGNT1-related conditions (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 538746). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt POMGNT1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg367 amino acid residue in POMGNT1. Other variant(s) that disrupt this residue have been observed in individuals with POMGNT1-related conditions (PMID: 17878207), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Muscular dystrophy-dystroglycanopathy Uncertain:1
The p.Arg367Cys variant in POMGNT1 has not been previously reported in the literature in individuals with muscular dystrophy-dystroglycanopathy, but has been identified in 0.01% (7/64016) of European (Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs36038536). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VCV000538746.9) as pathogenic by Labcorp Genetics, and as a variant of uncertain significance by Natera Inc. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Arg367Cys variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3_moderate (Richards 2015). -
Muscle eye brain disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at